188 related articles for article (PubMed ID: 30578588)
21. Factors Associated With the Choice of Radiation Therapy Treatment Facility in Head and Neck Cancer.
Sullivan CB; Al-Qurayshi Z; Anderson CM; Seaman AT; Pagedar NA
Laryngoscope; 2021 May; 131(5):1019-1025. PubMed ID: 32846018
[TBL] [Abstract][Full Text] [Related]
22. Small Cell and Squamous Cell Carcinomas of the Head and Neck: Comparing Incidence and Survival Trends Based on Surveillance, Epidemiology, and End Results (SEER) Data.
Bean MB; Liu Y; Jiang R; Steuer CE; Patel M; McDonald MW; Higgins KA; Beitler JJ; Shin DM; Saba NF
Oncologist; 2019 Dec; 24(12):1562-1569. PubMed ID: 31391295
[TBL] [Abstract][Full Text] [Related]
23. Survival impact and toxicity of metformin in head and neck cancer: An analysis of the SEER-Medicare dataset.
Stokes WA; Eguchi M; Amini A; Hararah MK; Ding D; McDermott JD; Bradley CJ; Karam SD
Oral Oncol; 2018 Sep; 84():12-19. PubMed ID: 30115470
[TBL] [Abstract][Full Text] [Related]
24. High-dose or low-dose cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer.
Chang CL; Yuan KS; Wu SY
Head Neck; 2017 Jul; 39(7):1364-1370. PubMed ID: 28370614
[TBL] [Abstract][Full Text] [Related]
25. Cost-Effectiveness of Sentinel Lymph Node Biopsy for Head and Neck Cutaneous Squamous Cell Carcinoma.
Quinn PL; Oliver JB; Mahmoud OM; Chokshi RJ
J Surg Res; 2019 Sep; 241():15-23. PubMed ID: 31004868
[TBL] [Abstract][Full Text] [Related]
26. A matched control study of treatment outcome in young patients with squamous cell carcinoma of the head and neck.
Verschuur HP; Irish JC; O'Sullivan B; Goh C; Gullane PJ; Pintilie M
Laryngoscope; 1999 Feb; 109(2 Pt 1):249-58. PubMed ID: 10890775
[TBL] [Abstract][Full Text] [Related]
27. Tumor location is an independent prognostic factor in head and neck Merkel cell carcinoma.
Smith VA; MaDan OP; Lentsch EJ
Otolaryngol Head Neck Surg; 2012 Mar; 146(3):403-8. PubMed ID: 22166964
[TBL] [Abstract][Full Text] [Related]
28. Sarcomatoid Carcinoma in the Head and Neck: A Population-Based Analysis of Outcome and Survival.
Ding L; Bi ZF; Yuan H; Zhao XH; Guan XD; Yao HR; Liu YM
Laryngoscope; 2021 Feb; 131(2):E489-E499. PubMed ID: 33135805
[TBL] [Abstract][Full Text] [Related]
29. [Neutrophil to lymphocyte ratio in peripheral blood: a novel independent prognostic factor in patients with head and neck squamous cell carcinoma].
Wu F; Wu LL; Zhu LX
Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):29-32. PubMed ID: 28104030
[No Abstract] [Full Text] [Related]
30. Prognostic and predictive values of immune infiltrate in patients with head and neck squamous cell carcinoma.
Zhang XM; Song LJ; Shen J; Yue H; Han YQ; Yang CL; Liu SY; Deng JW; Jiang Y; Fu GH; Shen WW
Hum Pathol; 2018 Dec; 82():104-112. PubMed ID: 30036594
[TBL] [Abstract][Full Text] [Related]
31. Socioeconomic factors and survival in patients with non-metastatic head and neck squamous cell carcinoma.
Xu C; Chen YP; Liu X; Tang LL; Chen L; Mao YP; Zhang Y; Guo R; Zhou GQ; Li WF; Lin AH; Sun Y; Ma J
Cancer Sci; 2017 Jun; 108(6):1253-1262. PubMed ID: 28383806
[TBL] [Abstract][Full Text] [Related]
32. Factors Associated with Recurrence and Regional Adenopathy for Head and Neck Cutaneous Squamous Cell Carcinoma.
Harris BN; Bayoumi A; Rao S; Moore MG; Farwell DG; Bewley AF
Otolaryngol Head Neck Surg; 2017 May; 156(5):863-869. PubMed ID: 28322123
[TBL] [Abstract][Full Text] [Related]
33. Merkel cell carcinoma: identification of prognostic factors unique to tumors located in the head and neck based on analysis of SEER data.
Smith VA; Camp ER; Lentsch EJ
Laryngoscope; 2012 Jun; 122(6):1283-90. PubMed ID: 22522673
[TBL] [Abstract][Full Text] [Related]
34. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
35. Success of salvage treatment: a critical appraisal of salvage rates for different subsites of HNSCC.
Matoscevic K; Graf N; Pezier TF; Huber GF
Otolaryngol Head Neck Surg; 2014 Sep; 151(3):454-61. PubMed ID: 24894422
[TBL] [Abstract][Full Text] [Related]
36. The prognostic value of USP7 and p53 in advanced hypopharyngeal carcinoma.
Sun J; Lin L; Zhang J; Hu C; Wang J
Ann Diagn Pathol; 2021 Apr; 51():151695. PubMed ID: 33460997
[TBL] [Abstract][Full Text] [Related]
37. Population-based analysis of prognostic indicators in sebaceous carcinoma of the head and neck.
Thomas WW; Fritsch VA; Lentsch EJ
Laryngoscope; 2013 Sep; 123(9):2165-9. PubMed ID: 23670399
[TBL] [Abstract][Full Text] [Related]
38. Association of Symptoms and Clinical Findings With Anticipated Outcomes in Patients With Recurrent Head and Neck Cancer.
Pipkorn P; Licata J; Kallogjeri D; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2018 Aug; 144(8):738-745. PubMed ID: 30003215
[TBL] [Abstract][Full Text] [Related]
39. Rural patients with oral squamous cell carcinoma experience better prognosis and long-term survival.
Harris JA; Hunter WP; Hanna GJ; Treister NS; Menon RS
Oral Oncol; 2020 Dec; 111():105037. PubMed ID: 33096312
[TBL] [Abstract][Full Text] [Related]
40. Treatment outcomes of unknown primary squamous cell carcinoma of the head and neck.
Hung YH; Liu SA; Wang CC; Wang CP; Jiang RS; Wu SH
PLoS One; 2018; 13(10):e0205365. PubMed ID: 30335795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
